FDA-Drug2017-10-25Class II
methylPREDNIsolone ACETATE, 40 MG/ML INJECTION SUSPENSION, 10 ML Vial, RXQ Compounding, Athens, OH --- NDC: 70731-0936-10
RXQ Compounding LLC
Hazard
Lack of Assurance of Sterility; autoclave parameters were not correct for one of two autoclaves used to sterilize the product.
Sold states
TX, LA, PA, MA, FL, and OH
Affected count
945 vials
Manufactured in
340 W State St Unit 9, Athens, OH, United States
Products
methylPREDNIsolone ACETATE, 40 MG/ML INJECTION SUSPENSION, 10 ML Vial, RXQ Compounding, Athens, OH --- NDC: 70731-0936-10
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0012-2018Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief